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The ability to successfully exploit genome edited organisms for the benefit of food
security and the environment will essentially be determined by the extent to which these
organisms fall under specific regulatory provisions. In many jurisdictions the answer to this
question is considered to depend on the genetic characteristics of the edited organism,
and whether the changes introduced in its genome do (or do not) occur naturally. We
provide here a number of key considerations to assist with this evaluation as well as a
guide of concrete examples of genetic alterations with an assessment of their natural
occurrence. These examples support the conclusion that for many of the common types
of alterations introduced by means of genome editing, the resulting organisms would
not be subject to specific biosafety regulatory provisions whenever novelty of the genetic
combination is a crucial determinant.
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INTRODUCTION
The advances presented by genome editing including oligonucleotide-directedmutagenesis (ODM)
and site-directed nuclease (SDN) technology have been widely recognized as a true revolution
in our abilities to alter and improve genomes. One of the fields where these techniques are
predicted to have a significant impact is plant breeding. Humans have selected genotypes more
adapted to their needs and have improved agricultural practices ever since the early Neolithic
period. The use of SDNs, and in particular CRISPR/Cas technology, will allow the introduction
of additional genomic alterations efficiently and with an unprecedented level of precision. This
technological innovation also presents regulatory challenges and leads to a number of questions.
First, are such genome edited organisms subject to specific regulatory provisions related to
biosafety? In many jurisdictions around the world, there is still legal uncertainty about this. And
second, if the answer to the first question is no, should genome edited organisms nevertheless
be subject to regulatory oversight that is stricter in any aspect than those which apply to
conventionally bred organisms? The impact these techniques will have on plant breeding will
greatly depend on how we answer these questions. To unlock the promise and potential of
genome editing and to take responsibility for its development to benefit society there is an
urgent need for a legal clarification based on correct scientific understanding. To support the
decision-making process we aim to describe what types of genetic alterations do and do not occur
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naturally and estimate to what extent various alterations along a
range from small to large genetic changes may occur in nature.
Genome editing also has a lot of potential for the introduction of
epigenetic changes. The scope of this paper, however, is limited to
alterations in the primary sequence of the genetic material.
GENOMES IN EVOLUTION
Genomes have evolved over millions of years starting from the
first development of living organisms, leading to the evolution of
a wide variety of species. Indeed, naturally occurring mutations
together with natural selection are the key factors driving
evolution. Many organisms have had the capacity to adjust to
specific environmental conditions and the plasticity of genomes
has been one of the factors contributing to the ability to survive
changing conditions. Over the years our understanding of the
mechanisms underlying this evolution has grown significantly.
On top of that, modern genome sequencing technology has
revealed to us what type of alterations have occurred during
evolution, domestication and breeding. If we want to determine
what types of combinations of genetic material should be
considered novel and are beyond what can “occur naturally by
mating and/or natural recombination”—the phrase used in the
EUGMOdefinition—it is important to have a closer look at these
alterations.
Genetic information has to be faithfully transmitted during
each cell division to allow the correct development and
functioning of each organism. It also needs to be faithfully
transmitted to the offspring in order to maintain species
boundaries and biodiversity. However, some level of change
needs to be generated to endow genetic information with
the plasticity required for organisms and species adaptation
to a changing environment. For this reason, most organisms
have evolved mechanisms to ensure a high but imperfect
fidelity in DNA replication, causing spontaneous mutations at
a low rate, and equally efficient and imperfect mechanisms
for repairing the DNA when damaged by endogenous or
environmental mutagenic agents such as UV or radiation
(Kunkel and Erie, 2015). This leads to a certain amount of natural
mutations continuously being introduced into the genomes of
all organisms. In the annual model plant Arabidopsis thaliana,
with a genome size that is about 24 times smaller than the
human genome, this mutation rate has been estimated to be
7 × 10−9 base substitutions per site per generation (Ossowski
et al., 2010), which is approximately one substitution per
genome per generation. In addition to these continuously arising
mutations, genomes are equipped with repetitive and mobile
genetic elements that promote additional mutations and genome
rearrangements, which are much more discontinuous during
evolution (Lisch, 2013). Finally, genomes are not completely
isolated within the species boundaries and different species
can exchange genetic information in nature through horizontal
transfer, as it has been shown for rice to millet (Diao et al.,
2006) or for the Poa to Festuca grass genera (Vallenback et al.,
2008), or even between kingdoms such as from Agrobacterium
to sweet potato (Kyndt et al., 2015). Moreover, the combination
of two complete genomes through interspecific crosses, has also
frequently occurred during plant genome evolution (Wendel,
2015).
All these fine or crude genetic changes are the raw material
on which selection operates allowing species adaptation and
evolution, both in the wild and under human direction. A look
at the mutations that are at the origin of new characters selected
during crop domestication and breeding shows that they cover
a wide range of mutation types and mechanisms (Olsen and
Wendel, 2013). These include point mutations causing amino
acid changes, premature translation terminations and changes
in transcript splicing or gene regulation. They also include
transposon insertions and large deletions causing changes in
coding or regulatory sequences in genes involved in plant and
inflorescence architecture, seed shattering and dormancy, grain
size and color, among many other characters that have been
subject to farmer-driven selection (Olsen andWendel, 2013). The
domestication and genetic improvement of crops to serve human
needs has also necessitated the incorporation of new genes
from other species or even the combination of two complete
genomes from different species. In fact, the domestication of
most crops is the result of the combination of many different
types of mutagenic events (see for instance Table 1 in Olsen
and Wendel, 2013). As an example, bread wheat domestication
required many independent mutations, including those at the
two genes controlling seed shattering in the wild emmer wheat
(Avni et al., 2017), different introgressions from wild related
species, a whole genome duplication event in emmer wheat, and
an interspecific cross between the domesticated emmer wheat
and the wild goatgrass (Aegilops tauschii) (Gornicki and Faris,
2014). In general, crop domestication has required a significant
number of mutations and genome rearrangements accumulated
in genomes, and this has also been true during the whole history
of crop breeding.
Whereas, all these individual mutations happened in nature
spontaneously, they were artificially selected and combined by
humans, who ultimately have made possible the large phenotypic
diversity of today’s crops and the radical differences crops present
when compared to wild plants. One may even argue that the
specific combinations of enhanced traits in all our crops are
something that never would have occurred nor maintained
without human intervention.
Plant breeding has been widely influenced by scientific
progress during modern history, which has allowed expanding
the range of techniques incorporated and boosted its
sophistication. One of the key factors during this process
was the increase in genetic variation available for breeding which
was achieved both by expanding the gene pool that could be used
for breeding and by enlarging the variability within the species
by mutagenesis. The expansion of the gene pool was obtained by
forcing crosses with increasingly distant species with the help,
among others, of in vitro culture techniques allowing the rescue
of the offspring of otherwise sterile crosses. Embryo rescue plays
an important role in plant breeding programmes and is expected
to retain or even broaden its significance, since plants obtained
by embryo rescue do not have to be considered as genetically
modified (Winkelmann et al., 2010).
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The increase in variability within species through mutagenesis
has been particularly successful and during the past 70 years
more than 3,200 new crop varieties have been developed through
mutation programs (cf. IAEA/FAO mutant variety database,
https://mvd.iaea.org/), predominantly using γ-ray irradiation,
but also other physical or chemical mutagens (Jankowicz-Cieslak
and Till, 2015).
It is clear that during evolution, domestication and plant
breeding a wide variety of genetic alterations have occurred
and are still being introduced and further exploited. But not
every type of alteration does or is likely to occur naturally.
Alterations that cannot occur naturally are considered novel. It
is for instance highly unlikely that organisms that are unrelated
at any higher taxonomic level exchange large amounts of genetic
material, although the examples given above show that horizontal
gene transfer (HGT) is known to occur also among sexually
incompatible eukaryotic/plant species.
THE NOVELTY CRITERION IN GMO
REGULATORY REGIMES
The Cartagena Protocol on Biosafety to the Convention
on Biological Diversity serves as a framework promoting
international harmonization in the legislation of GMOs
(Cartagena Protocol, 2000). This Protocol does not use the
term GMO but defines a “living modified organism” (LMO)
as “any living organism that possesses a novel combination of
genetic material developed through modern biotechnology.” In
the Cartagena Protocol, the mere use of a technique of modern
biotechnology is not enough to trigger regulatory oversight.
The resulting organism additionally needs to possess a novel
combination of genetic material. The combination of genetic
material needs to be beyond what can occur naturally by mating
and/or natural recombination. We deliberately use these latter
words because also the EU GMO definition uses a similar
phrasing. But what does “beyond what can occur naturally by
mating and/or natural recombination” actually mean? As a next
step we will therefore go over a list of concrete examples of
genetic alterations in different species and determine, based on
our current understanding of biology, whether these alterations
do occur naturally.
ALTERATIONS BEYOND WHAT CAN
OCCUR NATURALLY
InTable 1we provide 15 concrete examples of genetic alterations.
We do not specify by what means these alterations have been
introduced, but in line with the Cartagena Protocol definitions
they would only result in the formation of a specifically regulated
organism, if—besides having resulted in the formation of a
genetic combination that does not occur naturally by mating
and/or natural recombination—they also have been achieved by
a method that does not occur naturally. We propose that the
wording “does not occur” should be interpreted such that the
alterations are extremely unlikely to occur. Those that are more
likely to occur in nature or as a result of human intervention via
conventional breeding approaches would not be considered to
result in the formation of a specifically regulated organism.
The first two examples in Table 1 are about point mutations
of which we state that the likelihood of occurrence is very high.
This can be easily substantiated by performing sequence analyses
to estimate the occurrence of single nucleotide polymorphisms
(SNPs) in genes in different crops. In most genes one will find
dozens if not hundreds of SNPs. The more varieties of a crop are
subject to the analysis, the more SNPs are generally found. In a
separate appendix to this paper we provide such an analysis for
the acetolactate synthase (ALS) gene in Arabidopsis, wheat and
rice. This can be seen as an illustrative example for the occurrence
of SNPs in any gene in a crop. Similarly, one can perform
sequence analyses for determining the natural occurrence of the
other types of genetic alterations that we describe in Table 1, as
well.
EMERGING CONCLUSIONS AND
PRINCIPLES
From what we have described above it is apparent that quite a
lot of alterations are already occurring naturally. If we then go
over the more concrete examples of genetic alterations (Table 1),
in many occasions we get a rather clear picture. When such
alterations are deliberately introduced by means of techniques
that do not occur naturally, and the regulatory framework uses
novelty of the genetic combination as a criterion, then the
resulting organisms either would clearly classify as a specifically
regulated organism or would clearly not classify as such. This is
for instance the case for single point mutations or for deletions of
any size, which in that context would not be considered to result
in the formation of a specifically regulated organism, or for the
introduction of a transgene, which does result in the formation of
such an organism. The deliberate and simultaneous introduction
of a very large amount of specific point mutations would under
such legal approach also be considered to result in the formation
of a specifically regulated organism, even though each individual
mutation can occur naturally.
But there are also areas that are less clear. Exactly how many
point mutations can be simultaneously introduced before the
organism would become a specifically regulated organism? And
how many sequential base pairs of exogenous or recombinant
DNA, stemming from a non-crossable source, can be introduced
before the organism becomes a specifically regulated organism?
For sure, the more point mutations and the longer the stretch
of exogenous DNA, the less likely it is that this would occur
spontaneously in nature. Drawing a line will inevitably be
arbitrary, however for regulatory purposes this will be necessary.
Concerning the number of point mutations one could
perhaps debate why this is important to discuss in detail.
Yet, it might still be relevant to determine how many point
mutations are allowed to happen because it will largely determine
whether the resulting organism would have to be classified as
a specifically regulated organism or not. Are 10 simultaneous
point mutations acceptable? For sure the introduction of 40
SNPs is acceptable if they are introduced by means of an
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allele swap, where one existing allele is replaced by another
allele originating from the organisms’ gene pool. Another
question is whether the introduction of different mutations in
consecutive rounds of intervention at a certain point would
trigger the legislation. In other words: would the simultaneous
introduction of 200 point mutations be considered to lead to
the formation of a novel combination of genetic material and
therefore become a specifically regulated organism, whereas
the accumulated introduction of 200 single point mutations
would not? These intricate but realistic questions need pragmatic
answers.
RECOMMENDATIONS
The scheme and the concrete examples that we have presented
will help to clarify the regulatory status of genome edited
organisms within different regulatory frameworks. Several
competent authorities in the world have recently clarified the
scope of their legislation. USDA-APHIS has stated that organisms
with single point mutations, deletions of any size, and in which
genes from compatible species have been introduced are not a
regulated article under its biotechnology regulations. In their
view such organisms do not require specific regulatory scrutiny
because they could otherwise have been developed through
traditional breeding techniques. Conventionally bred varieties
are considered by the US regulators to present a risk level one
should not be forced to go below. In Argentina and Brazil
regulatory procedures have been introduced through which
the regulatory bodies can determine on a case-by-case basis
whether something would be regulated as a GMO (Whelan
and Lema, 2015). They use the novelty criterion from the
Cartagena Protocol LMO definition as their guiding principle.
The outcomes of these procedures so far show that also they do
not regard organisms with point mutations or (small) deletions,
or any other that could have occurred through conventional
breeding or by natural, spontaneous mutations, as GMOs that
require specific scrutiny.
In the EU, the recent ruling of the Court of Justice of
the European Union considers genome edited organisms as
GMOs that do not fall under the existing exemption for
organisms resulting from conventional mutagenesis (CJEU).1
The motivation of the ruling leaves very little room for a more
product-oriented interpretation of the phrase “has been altered
in a way that does not occur naturally by mating and or natural
recombination” in the EU GMO definition. The Court has not
used the novelty criterion, even though it could have. This implies
that organisms that have edits that can or do occur naturally,
will have to follow the same regulatory procedures as GMOs,
including a detailed analysis of possible risks. This does not
comply with the principles set out in the Cartagena Protocol
on Biosafety and would be disproportionate and scientifically
unsound. In the last few months, different proposals to solve
this situation have been proposed. First, the existing EU GMO
legal framework could be modified following for instance the
1http://curia.europa.eu/juris/document/document.jsf?text=&docid=207002&
pageIndex=0&doclang=EN&mode=req&dir=&occ=first&part=1&cid=6947981
proposal put forward by the Netherlands (Eriksson et al., 2018).
This would allow including genome editing techniques in the list
of techniques exempted from the regulation. Another option that
has also been proposed would be to revert the trend of the last 15
years limiting the latitude of scientist and risk assessors applying
the case-by-case approach to the risk analysis of GMOs as laid
down in Directives 90/220/EEC and 2001/18/EC (Casacuberta
and Puigdomènech, 2018). Whatever the path followed, the
principles developed in this article should help to adjust the
legal framework to each use of genome editing techniques and
perform a more proportionate risk assessment of genome edited
organisms.
It is important to note that being classified or not as an LMO
under the Cartagena Protocol, a GMO under EU legislation, a
regulated article under the USDA-APHIS plant pest legislative
framework, is not per se a safety related issue. However, it is true
that especially the EU GMO regulatory framework is foremost
applied to organisms that contain novel genetic combinations
beyond what does occur naturally by mating and/or natural
recombination, and subject these to pre-market risk assessment
under the pretext that these organisms may carry with them
a risk due to the genetic novelty per se. Mutations, whether
naturally occurring or man-made, such as limited nucleotide
changes could also result in phenotypic changes presenting
a hazard and the legislator has not seen a need to place
them under additional scrutiny. This is because the regulator
has considered the products of traditional breeding techniques
including mutagenesis to present a risk level that is acceptable.
Breeders are not required by law to perform a pre-market
risk assessment and get a market authorization for new varieties
based on the use of conventional breeding techniques including
conventional mutagenesis. But their products nevertheless need
to be safe for human consumption and the environment. If they
are not, other food and environmental legislation such as the
US legislation on food safety, the EU general food law and the
EU environmental liability legislation enters into force to correct
them and, if necessary, hold the developer accountable (De Jong
et al., 2018).
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